Title of article :
Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31: MV Pilepich, R Caplan, RW Byhardt, CA Lawton, MJ Ga
